论文部分内容阅读
目的:讨论小切口非超声乳化白内障摘除联合人工晶状体植入术在尿毒症血液透析患者的临床效果。方法:回顾性分析32例40眼有尿毒症史并行血液透析治疗的白内障患者施行小切口非超声乳化白内障摘除联合人工晶状体植入术,术后评价其疗效及并发症情况。结果:术后裸眼视力>0.3者35眼(87.5%),其中0.5～0.9者27眼,0.3～0.5者8眼;<0.3者5眼(12.5%),术中及术后各种并发症的发生率均很低。结论:小切口非超声乳化白内障摘除联合人工晶状体植入术具有术后视力恢复快、散光小、安全简便、不需要昂贵的设备等优点,是治疗尿毒症血液透析患者白内障的理想方法。
Objective: To discuss the clinical effect of small incision non-phacoemulsification cataract extraction combined with intraocular lens implantation in uremic hemodialysis patients. Methods: A retrospective analysis of 32 cases of 40 eyes with uremia history of hemodialysis treatment of cataract patients underwent a small incision non-phacoemulsification cataract extraction combined with intraocular lens implantation, postoperative evaluation of the efficacy and complications. Results: There were 35 eyes (87.5%) with uncorrected visual acuity> 0.3 after surgery, of which 27 eyes were 0.5-0.9, 8 eyes were 0.3-0.5, and 5 eyes (12.5%) were less than 0.3. There were various intraoperative and postoperative complications The incidence is very low. CONCLUSIONS: Small incision non-phacoemulsification combined with intraocular lens implantation has the advantages of quick recovery of visual acuity, small astigmatism, safety and convenience, no expensive equipment and so on. It is an ideal method for the treatment of cataract in uremic hemodialysis patients.